U.S. flag

An official website of the United States government

Format

Send to:

Choose Destination

Substance-Induced Psychotic Disorder

MedGen UID:
459695
•Concept ID:
C2987469
•
Mental or Behavioral Dysfunction

Definition

A psychotic disorder characterized by prominent hallucinations or delusions that have been determined to be etiologically linked to substance use, intoxication or withdrawal. [from NCI]

Term Hierarchy

CClinical test,  RResearch test,  OOMIM,  GGeneReviews,  VClinVar  
  • CROGVSubstance-Induced Psychotic Disorder

Professional guidelines

PubMed

Synthesizing the Evidence for Ketamine and Esketamine in Treatment-Resistant Depression: An International Expert Opinion on the Available Evidence and Implementation.
McIntyre RS, Rosenblat JD, Nemeroff CB, Sanacora G, Murrough JW, Berk M, Brietzke E, Dodd S, Gorwood P, Ho R, Iosifescu DV, Lopez Jaramillo C, Kasper S, Kratiuk K, Lee JG, Lee Y, Lui LMW, Mansur RB, Papakostas GI, Subramaniapillai M, Thase M, Vieta E, Young AH, Zarate CA Jr, Stahl S
Am J Psychiatry 2021 May 1;178(5):383-399. Epub 2021 Mar 17 doi: 10.1176/appi.ajp.2020.20081251. PMID: 33726522Free PMC Article
Antipsychotic-Induced Dopamine Supersensitivity Psychosis: Pharmacology, Criteria, and Therapy.
Chouinard G, Samaha AN, Chouinard VA, Peretti CS, Kanahara N, Takase M, Iyo M
Psychother Psychosom 2017;86(4):189-219. Epub 2017 Jun 24 doi: 10.1159/000477313. PMID: 28647739
Methamphetamine psychosis: epidemiology and management.
Glasner-Edwards S, Mooney LJ
CNS Drugs 2014 Dec;28(12):1115-26. doi: 10.1007/s40263-014-0209-8. PMID: 25373627Free PMC Article

Recent clinical studies

Etiology

Quinolone-induced psychosis: an updated review.
Palma-Alvarez RF, Duque-Yemail J, Ros-Cucurull E, Robles-Martínez M, Perea-Ortueta M, Grau-López L, Ramos-Quiroga JA
Actas Esp Psiquiatr 2020 May;48(3):126-37. Epub 2020 May 1 PMID: 32905605
Prediction of Onset of Substance-Induced Psychotic Disorder and Its Progression to Schizophrenia in a Swedish National Sample.
Kendler KS, Ohlsson H, Sundquist J, Sundquist K
Am J Psychiatry 2019 Sep 1;176(9):711-719. Epub 2019 May 6 doi: 10.1176/appi.ajp.2019.18101217. PMID: 31055966Free PMC Article
Characteristics and outcomes of young people with substance induced psychotic disorder.
O'Connell J, Sunwoo M, McGorry P, O'Donoghue B
Schizophr Res 2019 Apr;206:257-262. Epub 2018 Nov 22 doi: 10.1016/j.schres.2018.11.007. PMID: 30471979
Short-term outcome of substance-induced psychotic disorder in a large UK first episode psychosis cohort.
Thompson A, Marwaha S, Winsper C, Everard L, Jones PB, Fowler D, Amos T, Freemantle N, Singh SP, Marshall M, Sharma V, Birchwood M
Acta Psychiatr Scand 2016 Oct;134(4):321-8. Epub 2016 Aug 1 doi: 10.1111/acps.12623. PMID: 27479903
Towards diagnostic markers for the psychoses.
Lawrie SM, O'Donovan MC, Saks E, Burns T, Lieberman JA
Lancet Psychiatry 2016 Apr;3(4):375-85. doi: 10.1016/S2215-0366(16)00021-3. PMID: 27063388

Diagnosis

Prediction of Onset of Substance-Induced Psychotic Disorder and Its Progression to Schizophrenia in a Swedish National Sample.
Kendler KS, Ohlsson H, Sundquist J, Sundquist K
Am J Psychiatry 2019 Sep 1;176(9):711-719. Epub 2019 May 6 doi: 10.1176/appi.ajp.2019.18101217. PMID: 31055966Free PMC Article
A Systematic Review of the Symptom Profile and Course of Methamphetamine-Associated Psychosis(Substance Use and Misuse).
Voce A, Calabria B, Burns R, Castle D, McKetin R
Subst Use Misuse 2019;54(4):549-559. Epub 2019 Jan 29 doi: 10.1080/10826084.2018.1521430. PMID: 30693832
Characteristics and outcomes of young people with substance induced psychotic disorder.
O'Connell J, Sunwoo M, McGorry P, O'Donoghue B
Schizophr Res 2019 Apr;206:257-262. Epub 2018 Nov 22 doi: 10.1016/j.schres.2018.11.007. PMID: 30471979
Towards diagnostic markers for the psychoses.
Lawrie SM, O'Donovan MC, Saks E, Burns T, Lieberman JA
Lancet Psychiatry 2016 Apr;3(4):375-85. doi: 10.1016/S2215-0366(16)00021-3. PMID: 27063388
Catatonia in DSM-5.
Tandon R, Heckers S, Bustillo J, Barch DM, Gaebel W, Gur RE, Malaspina D, Owen MJ, Schultz S, Tsuang M, van Os J, Carpenter W
Schizophr Res 2013 Oct;150(1):26-30. Epub 2013 Jun 24 doi: 10.1016/j.schres.2013.04.034. PMID: 23806583

Therapy

A systematic review and meta-analysis of synthetic cathinone use and psychosis.
Daswani RR, Choles CM, Kim DD, Barr AM
Psychopharmacology (Berl) 2024 May;241(5):875-896. Epub 2024 Mar 6 doi: 10.1007/s00213-024-06569-x. PMID: 38446172
Quinolone-induced psychosis: an updated review.
Palma-Alvarez RF, Duque-Yemail J, Ros-Cucurull E, Robles-Martínez M, Perea-Ortueta M, Grau-López L, Ramos-Quiroga JA
Actas Esp Psiquiatr 2020 May;48(3):126-37. Epub 2020 May 1 PMID: 32905605
A Systematic Review of the Symptom Profile and Course of Methamphetamine-Associated Psychosis(Substance Use and Misuse).
Voce A, Calabria B, Burns R, Castle D, McKetin R
Subst Use Misuse 2019;54(4):549-559. Epub 2019 Jan 29 doi: 10.1080/10826084.2018.1521430. PMID: 30693832
Towards diagnostic markers for the psychoses.
Lawrie SM, O'Donovan MC, Saks E, Burns T, Lieberman JA
Lancet Psychiatry 2016 Apr;3(4):375-85. doi: 10.1016/S2215-0366(16)00021-3. PMID: 27063388
Cocaine-induced psychotic disorders: presentation, mechanism, and management.
Tang Y, Martin NL, Cotes RO
J Dual Diagn 2014;10(2):98-105. doi: 10.1080/15504263.2014.906133. PMID: 25392252

Prognosis

Prediction of Onset of Substance-Induced Psychotic Disorder and Its Progression to Schizophrenia in a Swedish National Sample.
Kendler KS, Ohlsson H, Sundquist J, Sundquist K
Am J Psychiatry 2019 Sep 1;176(9):711-719. Epub 2019 May 6 doi: 10.1176/appi.ajp.2019.18101217. PMID: 31055966Free PMC Article
A Systematic Review of the Symptom Profile and Course of Methamphetamine-Associated Psychosis(Substance Use and Misuse).
Voce A, Calabria B, Burns R, Castle D, McKetin R
Subst Use Misuse 2019;54(4):549-559. Epub 2019 Jan 29 doi: 10.1080/10826084.2018.1521430. PMID: 30693832
Short-term outcome of substance-induced psychotic disorder in a large UK first episode psychosis cohort.
Thompson A, Marwaha S, Winsper C, Everard L, Jones PB, Fowler D, Amos T, Freemantle N, Singh SP, Marshall M, Sharma V, Birchwood M
Acta Psychiatr Scand 2016 Oct;134(4):321-8. Epub 2016 Aug 1 doi: 10.1111/acps.12623. PMID: 27479903
The epidemiology and progression time from transient to permanent psychiatric disorders of substance-induced psychosis in Taiwan.
Chen WL, Hsieh CH, Chang HT, Hung CC, Chan CH
Addict Behav 2015 Aug;47:1-4. Epub 2015 Feb 21 doi: 10.1016/j.addbeh.2015.02.013. PMID: 25841087
Cocaine-induced psychotic disorders: presentation, mechanism, and management.
Tang Y, Martin NL, Cotes RO
J Dual Diagn 2014;10(2):98-105. doi: 10.1080/15504263.2014.906133. PMID: 25392252

Clinical prediction guides

Investigation of Siblings of Patients Diagnosed with Substance-Induced Psychotic Disorder in terms of Cognitive Functions and Clinical High-Risk State for Psychosis.
Çukurova M, Sancak B, Özdemir A
Psychopathology 2024;57(5):412-422. Epub 2024 Jun 17 doi: 10.1159/000538478. PMID: 38885619
Prediction of Onset of Substance-Induced Psychotic Disorder and Its Progression to Schizophrenia in a Swedish National Sample.
Kendler KS, Ohlsson H, Sundquist J, Sundquist K
Am J Psychiatry 2019 Sep 1;176(9):711-719. Epub 2019 May 6 doi: 10.1176/appi.ajp.2019.18101217. PMID: 31055966Free PMC Article
Brain metabolism in substance-induced psychosis and schizophrenia: a preliminary PET study.
Dragogna F, Mauri MC, Marotta G, Armao FT, Brambilla P, Altamura AC
Neuropsychobiology 2014;70(4):195-202. Epub 2014 Nov 27 doi: 10.1159/000366485. PMID: 25471704
Cocaine-induced psychotic disorders: presentation, mechanism, and management.
Tang Y, Martin NL, Cotes RO
J Dual Diagn 2014;10(2):98-105. doi: 10.1080/15504263.2014.906133. PMID: 25392252
Substance-induced psychoses: a critical review of the literature.
Fiorentini A, Volonteri LS, Dragogna F, Rovera C, Maffini M, Mauri MC, Altamura CA
Curr Drug Abuse Rev 2011 Dec;4(4):228-40. doi: 10.2174/1874473711104040228. PMID: 21999698

Recent systematic reviews

A systematic review and meta-analysis of synthetic cathinone use and psychosis.
Daswani RR, Choles CM, Kim DD, Barr AM
Psychopharmacology (Berl) 2024 May;241(5):875-896. Epub 2024 Mar 6 doi: 10.1007/s00213-024-06569-x. PMID: 38446172
A Systematic Review of the Symptom Profile and Course of Methamphetamine-Associated Psychosis(Substance Use and Misuse).
Voce A, Calabria B, Burns R, Castle D, McKetin R
Subst Use Misuse 2019;54(4):549-559. Epub 2019 Jan 29 doi: 10.1080/10826084.2018.1521430. PMID: 30693832
Efficacy, acceptability and tolerability of antipsychotics in patients with schizophrenia and comorbid substance use. A systematic review and meta-analysis.
Krause M, Huhn M, Schneider-Thoma J, Bighelli I, Gutsmiedl K, Leucht S
Eur Neuropsychopharmacol 2019 Jan;29(1):32-45. Epub 2018 Nov 22 doi: 10.1016/j.euroneuro.2018.11.1105. PMID: 30472164
Clinical characteristics of primary psychotic disorders with concurrent substance abuse and substance-induced psychotic disorders: A systematic review.
Wilson L, Szigeti A, Kearney A, Clarke M
Schizophr Res 2018 Jul;197:78-86. Epub 2017 Nov 5 doi: 10.1016/j.schres.2017.11.001. PMID: 29117908

Supplemental Content

Table of contents

    Practice guidelines

    • PubMed
      See practice and clinical guidelines in PubMed. The search results may include broader topics and may not capture all published guidelines. See the FAQ for details.
    • Bookshelf
      See practice and clinical guidelines in NCBI Bookshelf. The search results may include broader topics and may not capture all published guidelines. See the FAQ for details.

    Related information

    • PMC Articles
      Related information in PubMed Central Links
    • PubMed
      Related literature resources in PubMed

    Recent activity

    Clear Turn Off Turn On

    Your browsing activity is empty.

    Activity recording is turned off.

    Turn recording back on

    See more...